GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Stock Based Compensation

SyntekaBio (XKRX:226330) Stock Based Compensation : ₩468.6 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Stock Based Compensation?

SyntekaBio's Stock Based Compensation for the three months ended in Mar. 2025 was ₩91.9 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was ₩468.6 Mil.


SyntekaBio Stock Based Compensation Historical Data

The historical data trend for SyntekaBio's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Stock Based Compensation Chart

SyntekaBio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial 568.15 364.78 793.17 779.78 572.84

SyntekaBio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 196.14 174.83 136.93 64.94 91.88

SyntekaBio Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩468.6 Mil.


SyntekaBio Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of SyntekaBio's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


SyntekaBio Business Description

Traded in Other Exchanges
N/A
Address
187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512
SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio Headlines

No Headlines